Factors such
as the aging population, rising incidence of cardiovascular diseases,
increasing demand of minimally invasive procedures, and technological
advancements are expected to drive the growth of this market.The interventional
cardiology market is expected to reach USD 31.47 Billion by 2021 from USD 21.83
Billion in 2016, at a CAGR of 7.1%.
Get PDF Brochure Here: http://bit.ly/2uDGzna
Key players :
The major players in the interventional
cardiology market include Abbott Laboratories (U.S.), Boston Scientific
Corporation (U.S.), B. Braun Melsungen AG (Germany), Cordis Corporation (U.S.),
C.R. Bard, Inc. (U.S.), Medtronic plc (U.S.), and Terumo Corporation (Japan).
About Report :
On the basis of type, the angioplasty stent market is segmented
into drug-eluting stents, bare-metal stents, and bioabsorbable stents. On the
basis of type, the catheters market is segmented into IVUS/OCT, angiography
catheters, and guiding catheters. In 2016, the angiography catheters segment is
expected to account for the largest share of the market.On the basis of type,
the EVAR stent grafts market is segmented into abdominal aortic aneurysms and
thoracic aortic aneurysms. In 2016, the abdominal aortic aneurysms segment is
expected to account for the largest share primarily due to the rising incidence
of smoking and hypertension.
Value Addition for the Buyer:
This
report aims to provide insights into the global interventional cardiology &
peripheral vascular devices market. It provides valuable information on
interventional cardiology & peripheral vascular devices product segment and
end user. Details on regional markets for these segments are also presented in
this report. In addition, leading players in the market are profiled to
understand the strategies undertaken by them to be competitive in this market.
To Know More About It: http://bit.ly/2uE8eog
No comments:
Post a Comment